This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by García, S. I. Articles by Pirola, C. J. Search for Related Content PubMed PubMed Citation Articles by García, S. I. Articles by Pirola, C. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Related Collections Animal models of human disease Hypertension - basic studies Gene therapy

(Hypertension. 2001;37:365.)
© 2001 American Heart Association, Inc.

Scientific Contributions

Antisense Inhibition of Thyrotropin-Releasing Hormone Reduces Arterial Blood Pressure in Spontaneously Hypertensive Rats

Silvia I. García; Azucena L. Alvarez; Patricia I. Porto; Victoria M. Garfunkel; Sammuel Finkielman; Carlos J. Pirola

From the Cardiología Molecular, Instituto de Investigaciones Médicas A. Lanari, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.

Correspondence to Dr Carlos J. Pirola, Instituto de Investigaciones Médicas A. Lanari, Combatientes de Malvinas 3150, 1427- Buenos Aires, Argentina. E-mail cjpirola{at}ciudad.com.ar/sigarcia@ciudad.com.ar

Thyrotropin-releasing hormone (TRH) plays an important role in central cardiovascular regulation. Recently, we described that the TRH precursor gene overexpression induces hypertension in the normal rat. In addition, we published that spontaneously hypertensive rats (SHR) have central extrahypothalamic TRH hyperactivity with increased TRH synthesis and release and an elevated TRH receptor number. In the present study, we report that intracerebroventricular antisense (AS) treatment with a phosphorothioate oligonucleotide against the TRH precursor gene significantly diminished up to 72 hours and in a dose-dependent manner the increased diencephalic TRH content, whereas normalized systolic blood pressure (SABP) was present in the SHR compared with Wistar-Kyoto (WKY) rats. Although basal thyrotropin was higher in SHR compared with WKY rats and this difference disappeared after antisense treatment, no differences were observed in plasma T4 or T3 between strains with or without AS treatment, indicating that the effect of the AS on SABP was independent of the thyroid status. Because the encephalic renin-angiotensin system seems to be crucial in the development and/or maintenance of hypertension in SHR, we investigated the effect of antisense inhibition of TRH on that system and found that TRH antisense treatment significantly diminished the elevated diencephalic angiotensin II (Ang II) content in the SHR without any effect in control animals, suggesting that the Ang II system is involved in the TRH cardiovascular effects. To summarize, the central TRH system seems to be involved in the etiopathogenesis of hypertension in this model of essential hypertension.

Key Words: angiotensin II • antisense • blood pressure • hypertension • SHR • thyroid hormones • TRH • TSH

This article has been cited by other articles:

				A. A. da Silva, J. M. do Carmo, B. Kanyicska, J. Dubinion, E. Brandon, and J. E. Hall Response to Thyrotropin-Releasing Hormone Precursor Gene Knocking Down Impedes Melanocortin-Induced Hypertension in Rats Hypertension, August 1, 2008; 52(2): e9 - e9. [Full Text] [PDF]

				M. S. Landa, S. I. Garcia, M. L. Schuman, A. Burgueno, A. L. Alvarez, F. E. Saravia, C. Gemma, and C. J. Pirola Knocking down the diencephalic thyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1388 - E1394. [Abstract] [Full Text] [PDF]

				O. Gumieniak, T. S. Perlstein, J. S. Williams, P. N. Hopkins, N. J. Brown, B. A. Raby, and G. H. Williams Ala92 Type 2 Deiodinase Allele Increases Risk for the Development of Hypertension Hypertension, March 1, 2007; 49(3): 461 - 466. [Abstract] [Full Text] [PDF]

				O. Gumieniak, S. Hurwitz, T. S. Perlstein, U. C. Ngumezi, P. N. Hopkins, X. Jeunemaitre, and G. H. Williams Aggregation of High-Normal Thyroid-Stimulating Hormone in Hypertensive Families J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5985 - 5990. [Abstract] [Full Text] [PDF]

				N. Agirregoitia, J. Gil, F. Ruiz, J. Irazusta, and L. Casis Effect of Aging on Rat Tissue Peptidase Activities J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2003; 58(9): B792 - 797. [Abstract] [Full Text] [PDF]

				S. I. Garcia, M. S. Landa, P. I. Porto, A. L. Alvarez, M. Schuman, S. Finkielman, and C. J. Pirola Thyrotropin-Releasing Hormone Decreases Leptin and Mediates the Leptin-Induced Pressor Effect Hypertension, February 1, 2002; 39(2): 491 - 495. [Abstract] [Full Text] [PDF]

				H. E. De Wardener The Hypothalamus and Hypertension Physiol Rev, October 1, 2001; 81(4): 1599 - 1658. [Abstract] [Full Text] [PDF]

				S. I. Garcia, P. I. Porto, G. Dieuzeide, M. S. Landa, T. Kirszner, Y. Plotquin, C. Gonzalez, and C. J. Pirola Thyrotropin-Releasing Hormone Receptor (TRHR) Gene Is Associated With Essential Hypertension Hypertension, September 1, 2001; 38(3): 683 - 687. [Abstract] [Full Text] [PDF]